Provided by Tiger Trade Technology Pte. Ltd.

Silexion Therapeutics Corp

0.3400
-0.0454-11.78%
Post-market: 0.3138-0.0262-7.71%19:59 EDT
Volume:36.97M
Turnover:15.81M
Market Cap:1.96M
PE:-0.01
High:0.3546
Open:0.3350
Low:0.3241
Close:0.3854
52wk High:42.60
52wk Low:0.3241
Shares:5.76M
Float Shares:5.67M
Volume Ratio:1.51
T/O Rate:651.72%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-56.4473
EPS(LYR):-89.5962
ROE:-897.46%
ROA:-123.27%
PB:44.48
PE(LYR):0.00

Loading ...

Nov 19, 2024

Major Issues Report

Form 8-K - Current report
Nov 14, 2024

Major Issues Report

Form 8-K - Current report
Nov 14, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 01, 2024

Major Issues Report

Form 8-K - Current report
Oct 31, 2024

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Oct 15, 2024

Correspondence

Form CORRESP - Correspondence
Oct 09, 2024

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Oct 01, 2024

Major Issues Report

Form 8-K - Current report
Sep 24, 2024

Major Issues Report

Form 8-K - Current report
Sep 19, 2024

Major Issues Report

Form 8-K - Current report
Sep 17, 2024

Correspondence

Form CORRESP - Correspondence
Sep 10, 2024

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Sep 09, 2024

Major Issues Report

Form 8-K - Current report
Aug 29, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 22, 2024

Beneficial Ownership Change

Form SC 13D - General Statement of Acquisition of Beneficial Ownership
Aug 22, 2024

Beneficial Ownership Change

Form SC 13D - General Statement of Acquisition of Beneficial Ownership
Aug 22, 2024

Major Issues Report

Form 8-K - Current report
Jul 26, 2024

Business Combinations

Form 425 - Prospectuses and communications, business combinations
Jul 26, 2024

Business Combinations

Form 425 - Prospectuses and communications, business combinations
Jul 16, 2024

Correspondence

Form CORRESP - Correspondence